Joseph Schwartz

Stock Analyst at Leerink Partners

(0.67)
# 2412
Out of 5,356 analysts
180
Total ratings
33.06%
Success rate
-6.59%
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
FULC Fulcrum Therapeutics
Upgrades: Outperform
4 12
7.24 65.75% 4 May 23, 2025
RGLS Regulus Therapeutics
Downgrades: Market Perform
7
8.28 -15.46% 3 Apr 30, 2025
MAZE Maze Therapeutics
Initiates Coverage On: Outperform
28
13.25 111.32% 1 Feb 25, 2025
TVTX Travere Therapeutics
Maintains: Outperform
20 40
14.81 170.09% 6 Oct 11, 2024
APLT Applied Therapeutics
Maintains: Outperform
11 14
0.38 3584.21% 2 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Jul 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12 12
4.57 162.58% 6 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 8
2.67 199.63% 2 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 2
0.06 3233.33% 5 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
1.22 -18.03% 4 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10
n/a n/a 3 Dec 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
6
4.3 39.53% 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
44 40
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80 115
n/a n/a 3 Jun 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
48
51.7 -7.16% 1 Mar 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 18
16.57 8.63% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 20
14.06 42.25% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
33 34
35.33 -3.76% 1 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
122 130
56.6 129.68% 10 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
160
42.89 273.05% 10 Jan 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
148 163
174.29 -6.48% 15 Jan 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 2
n/a n/a 6 Dec 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
1.28 681.25% 7 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 33
1.5 2100% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 12
8.18 46.7% 6 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 108
36.95 192.29% 6 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 50
73.03 -31.53% 3 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
64 52
n/a n/a 5 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 39
32.96 18.33% 1 May 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 4
0.85 370.59% 4 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 30
15.42 94.55% 2 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 50
36.22 38.05% 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 30
54.48 -44.93% 6 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
71 56
16.93 230.77% 1 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
124 4
50.15 -92.02% 6 Apr 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
6.12 128.76% 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
112 100
n/a n/a 6 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
n/a n/a 1 Oct 23, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 12
1.93 521.76% 1 Sep 26, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
n/a n/a 1 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 May 18, 2017